Xiangyang Lizhi

Vérifier le produit

← Retour à la bibliothèqueEntrée · LZH-016

lyophilized

KED · Vascular research

Vesugen

Vascular matrix bioregulatory tripeptide

Fiche techniqueLZH-016

Code: KED
Demi-vie: Short plasma; transcriptional effects persist
Voie de recherche: SC / sublingual (research)
Cibles moléculaires: Endothelial gene expression modulation
Découverte / divulgation: Khavinson group, 2000s
Pureté cible: ≥ 98 %
Conservation recommandée: −20 °C, à l'abri de la lumière. De 2 à 8 °C après reconstitution.

Synonymes

KED tripeptide

Aspect

White lyophilized powder

Solubilité

Water soluble

Séquence

Lys-Glu-Asp

Analystes examinant le chromatogramme HPLC du lot en cours — FIG. 201Analytical Lab
Identity, purity and main-peak area are checked by reversed-phase HPLC against an in-house reference standard for this sequence. The chromatogram you see on the certificate of analysis is generated at this exact bench, by the analysts who release the batch.

Technicien surveillant un réacteur en acier inoxydable pendant la montée en échelle — FIG. 202Scale-up Operations
When a sequence moves from milligram research lots to multi-gram research supply, the same chemistry is transferred onto jacketed stainless reactors. Temperature, agitation and reagent equivalents are logged in real time so that the larger batch matches the analytical fingerprint of the small one.

01

Vue d'ensemble

Vesugen is the Lys-Glu-Asp (KED) tripeptide within the Khavinson bioregulator family, focused on vascular wall and endothelial cell research.

02

Pharmacologie et mécanisme

Modulates endothelial gene expression, linked to transcription of vascular homeostasis and endothelial function factors.

03

Domaines de recherche

R.01

Vascular matrix bioregulatory tripeptide

Tool molecule in vascular aging, endothelial function and vascular matrix biology studies.

04

Notes structurales

Tripeptide Lys-Glu-Asp.

Séquence

Lys-Glu-Asp

Réservé à un usage de recherche. Ne constitue pas un avis médical et n'est destiné ni au diagnostic ni au traitement.

Molécules apparentées

Molécules apparentées

Catalogue complet →

GLP-1 RA4113.6 Da

Metabolic regulation

GIP / GLP-14813.5 Da

Dual receptor agonist

GIP / GLP-1 / GCG

Triple receptor agonist

Elamipretide639.8 Da

Mitochondrial targeting

CJC-1295 + Ipamorelin

GH pulse combination